Pathstone Family Office’s Hims & Hers Health HIMS Stock Holding History

Pathstone Family Office’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$414K	Buy	65,876 +1,000	+2%	+$7.44K	﹤0.01%	1135
2023 Q2	$610K	Buy	64,876 +824	+1%	+$8.17K	0.01%	666
2023 Q1	$635K	Sell	64,052 -187,356	-75%	-$1.64M	0.01%	591
2022 Q4	$5.13M	Hold	251,408	–	–	0.04%	277
2022 Q3	$1.4M	Buy	251,408 +220,582	+716%	+$1.33M	0.01%	575
2022 Q2	$140K	Sell	30,826 -141	-0.5%	-$601	﹤0.01%	978
2022 Q1	$165K	Buy	+30,967	New	+$153K	﹤0.01%	908
2021 Q4	–	Sell	-15,254	Closed	-$115K	–	926
2021 Q3	$115K	Buy	+15,254	New	+$129K	﹤0.01%	832

Other funds holding HIMS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IVMX

Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return

IVMX

Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return

Redpoint Management Woodside, California $201M AUM 39.14% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

NCPI

NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pathstone Family Office's HIMS Position: Q3 2023 in Review

Pathstone Family Office increased its Hims & Hers Health (HIMS) stake by 1.5% in Q3 2023, buying an estimated $7.44K and bringing the position to 65,876 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #1135.

Pathstone Family Office first reported a position in HIMS in Q3 2021 and has held it in 8 quarters since. The position peaked at $5.13M in Q4 2022. 191 funds tracked by Wall St. Rank hold HIMS as of Q3 2023.

Pathstone Family Office held 65,876 shares of Hims & Hers Health worth $414K as of Q3 2023.
Pathstone Family Office bought 1,000 Hims & Hers Health shares in Q3 2023, an estimated $7.44K.
Hims & Hers Health made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1135 holding.
Pathstone Family Office first reported a position in Hims & Hers Health in Q3 2021 and has held it in 8 quarters since.
Pathstone Family Office's Hims & Hers Health position peaked at $5.13M in Q4 2022.
191 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.